7u9i
From Proteopedia
(Difference between revisions)
m (Protected "7u9i" [edit=sysop:move=sysop]) |
|||
(One intermediate revision not shown.) | |||
Line 1: | Line 1: | ||
- | '''Unreleased structure''' | ||
- | + | ==Co-crystal structure of human CARM1 in complex with MT556 inhibitor== | |
- | + | <StructureSection load='7u9i' size='340' side='right'caption='[[7u9i]], [[Resolution|resolution]] 2.00Å' scene=''> | |
- | + | == Structural highlights == | |
- | + | <table><tr><td colspan='2'>[[7u9i]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7U9I OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=7U9I FirstGlance]. <br> | |
- | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2Å</td></tr> | |
- | [[Category: | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=44T:7-[5-S-(4-{[(4-ethylpyridin-3-yl)methyl]amino}butyl)-5-thio-beta-D-ribofuranosyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine'>44T</scene>, <scene name='pdbligand=UNX:UNKNOWN+ATOM+OR+ION'>UNX</scene></td></tr> |
- | [[Category: | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7u9i FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7u9i OCA], [https://pdbe.org/7u9i PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7u9i RCSB], [https://www.ebi.ac.uk/pdbsum/7u9i PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7u9i ProSAT]</span></td></tr> |
- | [[Category: Arrowsmith | + | </table> |
- | [[Category: | + | == Function == |
- | [[Category: | + | [https://www.uniprot.org/uniprot/CARM1_HUMAN CARM1_HUMAN] Methylates (mono- and asymmetric dimethylation) the guanidino nitrogens of arginyl residues in several proteins involved in DNA packaging, transcription regulation, pre-mRNA splicing, and mRNA stability. Recruited to promoters upon gene activation together with histone acetyltransferases from EP300/P300 and p160 families, methylates histone H3 at 'Arg-17' (H3R17me), forming mainly asymmetric dimethylarginine (H3R17me2a), leading to activate transcription via chromatin remodeling. During nuclear hormone receptor activation and TCF7L2/TCF4 activation, acts synergically with EP300/P300 and either one of the p160 histone acetyltransferases NCOA1/SRC1, NCOA2/GRIP1 and NCOA3/ACTR or CTNNB1/beta-catenin to activate transcription. During myogenic transcriptional activation, acts together with NCOA3/ACTR as a coactivator for MEF2C. During monocyte inflammatory stimulation, acts together with EP300/P300 as a coactivator for NF-kappa-B. Acts as coactivator for PPARG, promotes adipocyte differentiation and the accumulation of brown fat tissue. Plays a role in the regulation of pre-mRNA alternative splicing by methylation of splicing factors. Also seems to be involved in p53/TP53 transcriptional activation. Methylates EP300/P300, both at 'Arg-2142', which may loosen its interaction with NCOA2/GRIP1, and at 'Arg-580' and 'Arg-604' in the KIX domain, which impairs its interaction with CREB and inhibits CREB-dependent transcriptional activation. Also methylates arginine residues in RNA-binding proteins PABPC1, ELAVL1 and ELAV4, which may affect their mRNA-stabilizing properties and the half-life of their target mRNAs.<ref>PMID:16497732</ref> <ref>PMID:19405910</ref> |
- | [[Category: | + | == References == |
- | [[Category: | + | <references/> |
- | [[Category: | + | __TOC__ |
- | [[Category: | + | </StructureSection> |
- | [[Category: | + | [[Category: Homo sapiens]] |
- | [[Category: Halabelian | + | [[Category: Large Structures]] |
- | [[Category: | + | [[Category: Arrowsmith CH]] |
- | [[Category: | + | [[Category: Brown PJ]] |
- | [[Category: | + | [[Category: Dong A]] |
- | [[Category: | + | [[Category: Edwards AM]] |
- | [[Category: Perveen | + | [[Category: Fischer C]] |
- | [[Category: | + | [[Category: Gao YD]] |
- | [[Category: | + | [[Category: Gibson E]] |
- | [[Category: | + | [[Category: Hajian T]] |
- | [[Category: | + | [[Category: Halabelian L]] |
- | [[Category: | + | [[Category: Hicks J]] |
- | [[Category: | + | [[Category: Hutchinson A]] |
+ | [[Category: Li Y]] | ||
+ | [[Category: Nicholson B]] | ||
+ | [[Category: Perveen S]] | ||
+ | [[Category: Schneider S]] | ||
+ | [[Category: Seitova A]] | ||
+ | [[Category: Siliphaivanh P]] | ||
+ | [[Category: Sloman D]] | ||
+ | [[Category: Vedadi M]] | ||
+ | [[Category: Zeng H]] |
Current revision
Co-crystal structure of human CARM1 in complex with MT556 inhibitor
|
Categories: Homo sapiens | Large Structures | Arrowsmith CH | Brown PJ | Dong A | Edwards AM | Fischer C | Gao YD | Gibson E | Hajian T | Halabelian L | Hicks J | Hutchinson A | Li Y | Nicholson B | Perveen S | Schneider S | Seitova A | Siliphaivanh P | Sloman D | Vedadi M | Zeng H